CV Sciences Welcomes Delay in Hemp Regulations
News related to:CV Sciences, Inc · 2 min read
CV Sciences, Inc., a leading consumer wellness company, has welcomed the recent enactment of federal legislation that provides additional time for the development of a responsible, science-based regulatory framework for hemp-derived cannabinoid products. The new law delays the implementation of significant changes to the federal definition of hemp until December 11, 2026, giving Congress and the administration more time to establish comprehensive regulations.
The bill, which passed the U.S. House of Representatives with a bipartisan vote of 370-48 and the Senate by a vote of 90-6, was signed into law by President Donald Trump on September 1, 2026. This extension is intended to preserve continued access to naturally derived hemp products while allowing for the development of clear, consistent, and science-based standards.
Joseph Dowling, CEO of CV Sciences, expressed his support for the legislation, stating, "We welcome the enactment of this legislation and the additional time it provides for Congress to get the regulatory framework right."
According to Dowling, CV Sciences has been committed to quality, transparency, and responsible hemp-derived CBD products for over a decade. "We believe consumers deserve access to products that are manufactured to rigorous standards, accurately labeled, and supported by appropriate testing," he added.
The company emphasizes the need for clear and consistent rules that distinguish responsibly manufactured, naturally derived hemp products from those that may raise safety and regulatory concerns. "A clear federal framework would provide greater confidence throughout the supply chain and allow companies like CV Sciences to continue investing in quality, innovation, and consumer education," Dowling noted.
CV Sciences supports regulatory standards that promote responsible manufacturing and marketing of hemp-derived products, including appropriate product testing, accurate labeling, quality-control requirements, and transparency for consumers. The company plans to engage constructively with policymakers, industry organizations, and other stakeholders as discussions regarding the long-term federal regulatory framework continue.
The legislation is seen as an important step in establishing a more sustainable regulatory environment for the hemp industry. "While this legislation is an important step, it should be viewed as an opportunity rather than an endpoint," Dowling concluded. "We encourage policymakers to use this additional time to establish sensible, enforceable standards that protect consumers and responsible businesses alike."
CV Sciences, Inc. remains committed to developing and providing natural ingredients and products that are backed by science and research. The company's +PlusCBD™ brand, among others, continues to offer a range of hemp-extract products through various sales channels, including retail locations in the United States and online platforms.